Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Carisma Therapeutics Inc
CARM
Healthcare
Biotechnology
Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing its proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. It is developing a pipeline of product candidates, with an initial focus on advancing multiple ex vivo autologous and in vivo CAR-M therapies for the...
treatment of solid tumors. Its first product candidate, CT-0508, is an ex vivo gene-modified autologous chimeric antigen receptor-monocyte (CAR-Monocyte) cellular therapy intended to treat solid tumors that overexpress human epidermal growth factor receptor 2 (HER2). Its second product candidate, CT-0525, is an ex vivo gene-modified autologous chimeric antigen receptor-macrophage (CAR-Macrophage) cellular therapy intended to treat solid tumors that overexpress HER2. CT-1119 is a mesothelin-targeted CAR-Monocyte that is designed to treat patients with advanced mesothelin-positive solid tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:CARM)
New Post
View:
Posts & Comments
Threaded Posts
(43)
•••
Torrequebrada
X
View Profile
View Bullboard History
Comment by
Torrequebrada
on Jul 25, 2023 3:55pm
RE:SESEN / CARISMA
Well it looks like I am the only one here. Too bad. I try to get the reason for its UD$ 1.52 plus drop??
(43)
•••
Torrequebrada
X
View Profile
View Bullboard History
Post by
Torrequebrada
on Mar 10, 2023 1:35pm
SESEN / CARISMA
we,ve been fleeced by SESEN and now we,re realy get SC.....ed by Carisma. Man o Man it just never ends. What a bunch of scumbags
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(638)
•••
floatinketucky
X
View Profile
View Bullboard History
Comment by
floatinketucky
on Jan 24, 2022 6:51am
RE:4 BIOTECH STOCKS FACING FDA REJECTION!
(638)
•••
floatinketucky
X
View Profile
View Bullboard History
Post by
floatinketucky
on Jan 24, 2022 6:48am
sesn flying flamming turd
To catch is risk of splatter and burn. The market know for sure. Just look to the chart. More pain cometh. This song is Break it to me gently. But it was not gentle at all. The market
...more
(638)
•••
floatinketucky
X
View Profile
View Bullboard History
Post by
floatinketucky
on Jan 24, 2022 6:37am
BIG VOLUME NEW LOWS... NOT THE DARLIN. THE MARKET KNOWS.
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 20, 2021 2:34pm
SESN .... Volume is huge
sold into the strength Could re-load Cheers 1
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 20, 2021 2:29pm
SESN ..... $1.40 now ; )
Let's get it on !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 20, 2021 2:20pm
SESN ...mini pop
Better than nothing...... here come buying pressure ! Cheeers!
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 20, 2021 1:46pm
SESN .... in some here
Cheers !
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 20, 2021 1:14pm
SESN ...Hawkin this beotch
In PB mode.....and thru RBL currently at ~$1.29 Wit for lower price.... JMHO Down for a reason...it got smoked last August Cheers !
(248)
•••
Kingpin68
X
View Profile
View Bullboard History
Comment by
Kingpin68
on Aug 24, 2021 9:14am
RE:$4+
what a bummer
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Aug 24, 2021 7:36am
4 BIOTECH STOCKS FACING FDA REJECTION!
4 BIOTECH STOCKS FACING FDA REJECTION! Is it a full stop or a pause to their journey? SESN FGEN SPPI ARDX Read More: https://www.aviseanalytics.com/4-biotech-stocks-facing
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Jul 06, 2021 10:35pm
$4+
Well done to those who stuck this out a few years back
(8)
•••
CoolSoupy
X
View Profile
View Bullboard History
Post by
CoolSoupy
on Oct 11, 2019 1:41pm
Moving Day?
Nov 4th should see some major movement ?
(8)
•••
CoolSoupy
X
View Profile
View Bullboard History
Post by
CoolSoupy
on Aug 03, 2019 8:37am
August report
Two weeks from the qtrly and maybe a BLA update. Meanwhile penny flippers are busy as bee's doing their normal daily moves.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden